Indirect Evidence Against a Major Role of Kinins in Tourniquet-Shock by Use of Carboxypeptidase B

  • W. Stock
  • F. W. Eigler
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 8)


In pathophysiology of different shock-models kinins have often been considered as the essential factor of circulatory reactions (1, 2, 3, 14, 15). Kinins could as well be found in injuries as in edemas of extremities (4). In corresponding conditions the pro-teaseinhibitor Trasylol was given with good results, under the assumption that the kinin-formation is inhibited by this drug (5, 6, 13).


Survival Time Hind Limb Initial Volume Volumetric Method Shock Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1).
    BERALDO, W.T. Formation of Bradykinin in Anaphylactic and Peptone Shock Amer. J. Physiol. 163/283/1950Google Scholar
  2. 2).
    BROCKLEHURST, W.E., S.C. LAHIRI The Production of Bradykinin in Anaphylaxis J. Physiol. 160/15/1962Google Scholar
  3. 3).
    DAWSON, W., M.S. STARR, G.B. WEST Inhibition of Anaphylaktic Shock in the Rat by Antihistamines and Ascorbic Acid BR. J. Pharmac.Chemother. 27/249/1966Google Scholar
  4. 4).
    EDERY, H., G.P. LEWIS Kinin-Forming Activity and Histamine in Lymph after Tissue injury J. Physiol. 169/568/1963PubMedGoogle Scholar
  5. 5).
    EIGLER, F.W., W. STOCK Verminderung des postischämischen Extremitätenödems an der Ratte durch einen Proteinasehemmer Klin.Wschr. 46/1283/1968PubMedCrossRefGoogle Scholar
  6. 6).
    EIGLER, F.W., W. STOCK Wirkung eines Proteinaseninhibitors auf das Tourniquet-Syndrom der Ratte 1.: Beeinflussung des postischämischen Ödems in Abhängigkeit von Dosis und Zeitpunkt der Trasylolgabe Z. Ges. Exp. Med. (in press)Google Scholar
  7. 7).
    ERDöS, E.G., J.R. WOHLER, M.I. LEVINE Blocking of the in vivo Effects of Bradykinin and Kallidin with Carboxypeptidase B J. Pharmacol. Exp. Ther. 142/327/1963Google Scholar
  8. 8).
    GREEFF, K., K. SCHARNAGEL, R. LüHR, H. STROBACH Die Abnahme des Kininogen-Gehaltes des Plasmas beim toxischen anaphylaktischen und anaphylak-tiden Schock Naunyn-Schmiedbergs Arch. Exp. Path. u. Pharm. 253/235/1966CrossRefGoogle Scholar
  9. 9).
    HABERMANN, E. Probleme der Pathophysiologie des Kininsystems in: Neue Aspekte der Trasylol Therapie. Bnd.III S. 37, 1969, Hersg. G.L. Haberland, P. Matis, F.K. Schattauer Verlag Stuttgart-New YorkGoogle Scholar
  10. 10).
    KALLER, H. Die Beeinflussung experimentell erzeugter Ödeme durch Trasylol in: Neue Aspekte der Trasylol Therapie, Bnd. I, 1966, Hersg. R. Gross, G. Kroneberg F.K. Schattauer Verlag, StuttgartGoogle Scholar
  11. 11).
    KALLER, H. personal communicationGoogle Scholar
  12. 12).
    ROCHA E SILVA, M., A. Antonio Release of Bradykinin and the Mechanism of Production of Thermic Edema (45 C) in the Rats Paw Med. Exp. 3/371/1960Google Scholar
  13. 13).
    STOCK, W., F.W. EIGLER Wirkung eines Proteinaseninhibitors auf das Tourniquet-Syndrom der Ratte 2.: Verbesserung der Überlebensrate beim Tourniquet-Schock durch Trasylol Z. Ges. Exp. Med. (in press)Google Scholar
  14. 14).
    WERLE, E. Plasmakinine Dtsch. Med. Wschr. 92/1573/1967CrossRefGoogle Scholar
  15. 15).
    WEBSTER, M.E., W.R. CLARK Significance of the Callicrein-Callidinogen System in Shock Amer. J. Physiol. 197/406/1959Google Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • W. Stock
    • 1
  • F. W. Eigler
    • 1
  1. 1.Department of Experimental Surgery of the SurgicalUniversity ClinicCologneGermany

Personalised recommendations